Search Results - "K. I. Zhordania"

Long Non-Coding RNAs and microRNAs Groups in the Regulation of Expression Level of a Number of Tumor-Associated Genes in Ovarian Cancer by Pronina, I. V., Filippova, E. A., Brovkina, O. I., Burdennyy, A. M., Kazubskaya, T. P., Kushlinskii, D. N., Zhordania, K. I., Karpukhin, A. V., Loginov, V. I., Braga, E. A., Kushlinskii, N. E.

“…The search for interacting long non-coding RNAs (lncRNAs), microRNAs (miRNAs), and mRNAs of protein-coding genes through the mechanism of competing endogenous…”
Get full text

Clinical and histological criteria for sex cord ovarian stromal tumors by Beishembaev, A. М., Zhordania, K. I.

“…Aim : to identify clinical and histological criteria for sex cord ovarian stromal tumors (OSTs). Materials and Methods . The retrospective non-comparative…”
Get full text

Diagnostic potential of miRNA-135A1 in human papillomavirus associated cervical lesions by Elkin, D. S., Taubinskaya, M. I., Elkina, N. V., Faskhutdinov, R. S., Fedorova, M. D., Katargin, A. N., Zhordania, K. I., Mustafina, E. A., Grivachev, E. A., Pavlova, L. S., Vinokurova, S. V.

“…Introduction . Human papillomavirus (HPV) infection with high-risk HPVs is an etiological factor in the development of cervical cancer, with HPV type 16…”
Get full text

Methylation of Long Noncoding RNA Genes SNHG6, SNHG12, and TINCR in Ovarian Cancer by Lukina, S. S., Burdennyy, A. M., Filippova, E. A., Uroshlev, L. A., Pronina, I. V., Ivanova, N. A., Fridman, M. V., Zhordania, K. I., Kazubskaya, T. P., Kushlinskii, N. E., Loginov, V. I., Braga, E. A.

“…Ovarian cancer (OC) develops asymptomatically and escapes diagnosis until advanced stages, the feature contributing to a higher mortality rate. New prospects…”
Get full text

Clinical and histological features of purely stromal cell ovarian tumors by Beishembaev, A. M., Zhordania, K. I.

“…Aim: to identify clinical and histologic features of pure stromal ovarian tumors. Materials and methods. We analyzed the clinical data from patients treated…”
Get full text

Ovarian carcinosarcoma (a literature review) by Beishembaev, A. M., Zhordania, K. I., Choi, E. D., Turkmenov, A. A., Moldobekova, A. K.

“…Introduction. Despite that ovarian carcinosarcoma (OCS) is an extremely rare disease, it is of great medical and social importance by taking into account very…”
Get full text

The Role of Long Non-Coding RNA CCAT1 and SNHG14 in Activation of Some Protein-Coding Genes Associated with the Development of Ovarian Cancer by Brovkina, O. I., Pronina, I. V., Burdennyy, A. M., Uroshlev, L. A., Filippova, E. A., Fridman, M. V., Kazubskaya, T. P., Zhordania, K. I., Loginov, V. I., Kushlinskii, N. E., Braga, E. A.

“…Late diagnosis of ovarian cancer is one of the most important problems in its treatment. Long non-coding RNA (lncRNA) are a poorly studied, but promising type…”
Get full text

Clinical and statistical analysis of ovarian cancer incidence rate and identification of a subgroup of patients with BRCA1/2 mutations in the russian federation by Ryazhenov, V, Gorokhova, S G, Zhordania, K I, Payanidi, Yu G, Bunyatyan, N D

“…Keeping in mind a relatively high prevalence of BRCA1/2 mutations in patients with OC, it is necessary to match the financial resources required (expected) to…”
Get full text

RARE FORMS OF UTERINE LEIOMYOMAS (description of a case) by Payanidi, Yu. G., Zhordania, K. I., Stilidi, I. S., Zakharova, T. I., Bokhyan, V. Yu

“…Leiomyomas predominate among benign nonepithelial tumors of the corpus uteri. Leiomyoma is commonly an asymptomatic tumor and detectable in most cases at…”
Get full text

Comparative analysis of serum and tumor vascular endothelial growth factor, insulin-like growth factor 1, matrix metalloproteinase 7 levels in patients with ovarian cancer by Plieva, Ya. Z., Ermilova, V. D., Tereshkina, I. V., Kushlinskiy, D. N., Shelepova, V. M., Utkin, D. O., Khokhlova, S. V., Dvorova, E. K., Payanidi, Yu. G., Zhordania, K. I.

“…Aim: To perform a comparative analysis with simultaneous measurement of vascular endothelial growth factor (VEGF), insulin-like growth factor 1 (IGF1) and…”
Get full text

Genetic and epigenetic profiling of the BRCA1 / 2 genes in solitary ovarian cancer and multiple primary ovarian tumors by M. E. Esenova, Yu. G. Payanidi, S. V. Vinokurova, A. S. Shevchuk, M. N. Tikhonovskaya, K. I. Zhordania

“…Background. Ovarian cancer is a complex and poorly studied disease that kills nearly 70–80 % of patients. Therefore, practitioners are interested in any…”
Get full text

Features of metastasis and recurrence in patients with stromal cell ovarian tumors by Beyshembaev, A. M., Temirova, M. Sh, Zhordania, K. I., Kashurnikov, A. Yu

“…Objective: a retrospective analysis of association of the tumor stage of stromal cell ovarian tumors with the frequency of recurrence and development of…”
Get full text

The intravenous leiomyomatosis by Stilidi, I S, Bokhian, V Iu, Paianidi, Iu G, Zhordania, K I

Get more information

ARTIFICIAL MENOPAUSE AND EXPERIENCE OF CIMICIFUGA EXTRACT USE (KLIMADYNON) by Yu. G. Payanidi, K. I. Zhordania

“…Advances made in oncogynecology and improvements of surgical, radiation, and drug treatment provided relatively good sur- vival rates in patients with female…”
Get full text

Early ovarian cancer: our view of the problem by K. I. Zhordania, S. V. Khokhlova

“…The paper considers some pathogenetic aspects of ovarian tumor development, on the basis of which the authors recommend to perform more aggressive chemotherapy…”
Get full text

EXPRESSION OF THE TUMOR-ASSOCIATED PROTEINS IN THE OVARIAN CANCER by T. S. Bobrova, K. I. Zhordania, Yu. V. Chuyev

“…With the help of monoclonal antibodies (MCA-1, MCA-3, G1 class immunoglobulins) and polyspecific antiserum (As) by means of immunoblotting (IB) the increase of…”
Get full text

Quantification analysis of the expression of tumor-associated proteins in serum samples from patients with ovarian cancer and those with other tumor location. Possibilities of their use in the diagnosis and estimation of the extent of a tumorous process by T. S. Bobrova, Yu. V. Chuyev, K. I. Zhordania

“…The specific features of the expression of tumor-associated proteins (TAP) were immunologically studied in the sera of patients with ovarian cancer (OC) and…”
Get full text

IMMUNOPROPHYLAXIS OF CANCER OF THE CERVIX UTERI by V. P. Kozachenko, G. Z. Chkagua, K. I. Zhordania, Yu. G. Payanidi

“…The prevention of cancer of the cervix uteri (CCU) is an interdisciplinary problem that may be solved only via joint efforts of gynecol- ogists, oncologists,…”
Get full text

Uterine leiomyomas and metastases: description of a case by T. I. Zakharova, Yu. G. Payanidi, K. I. Zhordania, N. I. Lazareva, E. V. Korzhevskaya

“…Leiomyomas predominate among benign nonepithelial tumors of the corpus uteri. According to the data available in the literature, they occur in 25% of women…”
Get full text

Use of inhibin B in recurrent ovarian granulosa cell tumors by A. M. Beishembayev, N. V. Lyubimova, V. M. Abayev, K. I. Zhordania, V. A. Khailenko

“…Early diagnosis of recurrent ovarian granulose cell tumors (OGCT) remains an urgent problem of modern oncogynecology. Inhibin B is one of the most potentially…”
Get full text